Nintedanib appears to stabilize lung function in patients with systemic sclerosis-associated ILD exhibiting a PPF phenotype.
Lupus can affect the lungs in many ways and lead to potential complications and increased risk of death. Pulmonary (lung) function tests (PFTs) are capable of identifying abnormalities that may ...